Abstract
Background The novel SARS-CoV-2 virus that causes Coronavirus disease (COVID-19) has redefined global health and response to Acute Respiratory Infection (ARI). The outbreak of a cluster of influenza-like illnesses in Wuhan, China, has morphed into a pandemic in the last quarter of 2019, stretching from South East Asia to Europe, The Americas, Africa, and the Australian subcontinent.
Materials and Methods We shall utilize a cross-sectional, observational design to investigate the prevalence of symptoms of depression among outpatients with ARI and describe the characteristics of outpatients with ARI in Kaduna State.
Results The prevalence of symptoms of depression was 19.6% for respondents with symptoms of ARI, and 14.4%, for those without symptoms of ARI. On no risk of depression, we had a higher proportion of the respondents without symptoms of ARI (86%) than those with symptoms of depression (80%) (M=318.4, SD=29.62 case, and M=344.0, SD=14.2 control, r=0.88, CI=13.5 to 6.5, P=0.000952). Likewise, in the category with mild risk of depression, respondents without symptoms of ARI were fewer (10%) than those with symptoms of depression (15%) (M=58.4, SD=26.0 case, and M=42.1, SD=12.7 control, r=0.86, CI=11.8 to 5.8, P=0.0136. There was no significant difference between respondents with symptoms of ARI and without symptoms of ARI in the categories of moderate (M=13.6, SD=5.1 case, and M=11.6, SD=4.6 control, r=0.87, CI=2.3 to 2.1, P=0.178) and high (M=5.6, SD=2.5 case, and M=4.4, SD=3.2 control, r=0.61, CI=1.2 to 1.5, P=0.174) risk of depression.
Conclusion Symptoms of depression were commoner among respondents who presented with symptoms of Acute Respiratory Infection (ARI) at the Outpatient Department (OPD). However, further explanatory research is needed to establish causality.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NA
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The researcher sought and obtained ethical approval (NHREC/17/03/2018) from the Kaduna State Ministry of Health—only respondents who willingly gave written informed consent after a clear protocol explanation participated in the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
data available on request to the corresponding author
Abbreviations
- ARI
- Acute Respiratory Infections
- BDI
- Beck’s Depression Inventory
- CEPI
- Epidemic Preparedness and Innovation
- CHEW
- Community Health Environmental Worker
- CHO
- Community Health Officer
- COVAX
- Coalition for COVID-19 vaccine led by WHO
- DALY
- Disability Adjusted Life Year
- DSM-IV
- Diagnostic and Statistical Manual IV for Mental Health
- LGA
- Local Government Area
- LMIC
- Low and Middle-Income Countries
- LRTI
- Lower Respiratory Tract Infection
- NLR
- Neutrophil to Lymphocyte Ratio
- NPI
- Non-Pharmaceutical Interventions
- PCR
- Polymerase Chain Reaction
- PHC
- Primary Health Care
- PHEIC
- Public Health Emergency of International Concern
- PPE
- Personal Protective Equipment
- PPS
- Proportional Probability Size
- RDT
- Rapid Diagnostic Test
- RSV
- Respiratory Syncytial Virus
- RTI
- Respiratory Tract Infection
- RT-PCR
- Reverse Transcriptase Polymerase Chain Reaction
- SARS-CoV-2
- Severe Acute Respiratory Syndrome Coronavirus 2
- SPSS
- Statistical Package for Social Sciences
- UNICEF
- United Nations Children Funds
- URTI
- Upper Respiratory Tract Infection
- WHO
- World Health Organization
